| Stanford University School of Medicine | ||
| City: Stanford | State: CA | |
|
Links:
Commentary:Stanford_CME_Commercial_Support_Policy.doc Stanford_ICOI_Policy.pdf Stanford_Statement_on_Faculty_Discipline.doc Stanford_University_Code_of_Conduct.pdf Stanford Industry Interactions Policy Stanford_Med_School_COI_Curriculum_Information.doc Stanford University School of Medicine’s conflict of interest policy is exemplary in many areas. Of important note is Stanford's gold-standard policy on industry support of CME, and public disclosures by faculty. In addition, there is a total ban on gifts and on-site meals, thorough restrictions on speaking relationships, and an unusually strong disclosure policy, requiring posting of all financial relationships on a website accessible to the public.
This institution's evaluation was last updated: 12/15/2009 |
||
| Gifts & Meals | ![]() |
Gifts may not be accepted by any faculty or staff member on campus. On-site industry sponsored meals are also prohibited. |
| Consulting relationships | ![]() |
Institutional review of all consulting relationships is required by Stanford University School of Medicine. The policies provided did not include a requirement that consulting contracts be fair or compensation commensurate to the task. |
| Industry-funded speaking relationships | ![]() |
Participation in "speaker's bureaus" is not permitted. Additionally, the faculty member must choose and prepare the lecture content without influence of the industry. |
| Disclosure | ![]() |
"All faculty must disclose all personal financial relationships on an annual basis for posting in the School's publicly accessible Community Academic Profiles (CAP) system." |
| Pharmaceutical samples | ![]() |
This institution has a strong samples policy, which prevents samples from going directly to doctors (they are controlled and dispensed by the pharmacy) and allows them only where specially approved by Stanford Hospitals and Clinics. Where approved they are limited to only 10 different |
| Purchasing & Formularies | ![]() |
Equipment and drug procurement committee members with financial interests must disclose them, but whether the staff member must recuse him/herself from the purchasing decision is at the discretion of the purchasing unit. |
| Industry Sales Representatives | ![]() |
Sales and marketing representatives are not permitted in patient-care areas except by appointment to provide in-service training. Sales and marketing representatives are permitted in non-patient care areas by appointment only, normally only for evaluation of new purchases of equipment and devices, or in-service training. Pharmaceutical sales representatives are not explicitly prohibited from the site, although the effect of this policy may be to significantly limit their presence. |
| On-campus Education | ![]() |
This institution has banned direct funding of CME by industry, and allows funding designation only by general areas of interest. By removing the potential for funding bias in therapeutic areas related to frequently promoted products, this institution’s policy is exemplary. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | ![]() |
This strong policy language broadly bans the receipt of "compensation, including the defraying of costs, for simply attending a CME or other activity or conference (that is, if the individual is not speaking or otherwise actively participating or presenting at the event)." |
| Industry Support for Scholarships & Funds for Trainees | ![]() |
The recipients of scholarships and trainee funds are to be selected by the institution. |
| Medical school curriculum | ![]() |
This institution has a curricular component focused on financial conflicts of interest and their management. This policy could be strengthened by demonstrating greater focus on colficts of interest issues outside of the research framework. |
| Do the policies specify an oversight mechanism? | ![]() |
Oversight established |
| Are there explicit sanctions for noncompliance? | ![]() |
Sanctions referenced |
| Model policy | |
| Good progress toward model policy | |
| No policy, or policy unlikely to have a substantial effect on behavior | |
| Did not report | |
| Policy not relevant to this institution (e.g., does not make purchasing decisions) | |